CSL Ltd (CSLLY)
91.71
-1.20
(-1.29%)
USD |
OTCM |
Nov 14, 16:00
CSL Price: 91.71 for Nov. 14, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 14, 2024 | 92.37 | 92.60 | 91.68 | 91.71 | 36810.00 |
Nov 13, 2024 | 91.90 | 93.01 | 91.90 | 92.91 | 43074.00 |
Nov 12, 2024 | 93.50 | 93.75 | 92.88 | 92.90 | 37808.00 |
Nov 11, 2024 | 94.63 | 94.72 | 94.20 | 94.50 | 38664.00 |
Nov 08, 2024 | 94.42 | 94.42 | 93.05 | 93.50 | 34779.00 |
Nov 07, 2024 | 94.78 | 95.10 | 94.56 | 94.94 | 30594.00 |
Nov 06, 2024 | 91.90 | 96.01 | 91.90 | 93.92 | 24637.00 |
Nov 05, 2024 | 96.79 | 96.79 | 93.68 | 94.67 | 44460.00 |
Nov 04, 2024 | 94.29 | 94.73 | 93.65 | 93.78 | 52509.00 |
Nov 01, 2024 | 93.40 | 93.54 | 92.87 | 92.92 | 31871.00 |
Oct 31, 2024 | 93.70 | 93.92 | 93.42 | 93.76 | 47373.00 |
Oct 30, 2024 | 97.09 | 97.09 | 94.85 | 94.95 | 56358.00 |
Oct 29, 2024 | 90.18 | 96.00 | 90.18 | 95.84 | 36395.00 |
Oct 28, 2024 | 98.00 | 98.75 | 96.37 | 96.41 | 22911.00 |
Oct 25, 2024 | 97.66 | 99.55 | 97.06 | 97.35 | 17843.00 |
Oct 24, 2024 | 100.56 | 100.56 | 97.36 | 97.93 | 26084.00 |
Oct 23, 2024 | 98.22 | 98.83 | 96.69 | 97.08 | 22912.00 |
Oct 22, 2024 | 99.33 | 100.75 | 98.54 | 99.22 | 13123.00 |
Oct 21, 2024 | 101.00 | 101.44 | 100.36 | 100.87 | 18974.00 |
Oct 18, 2024 | 100.86 | 101.14 | 100.80 | 101.12 | 17685.00 |
Oct 17, 2024 | 100.87 | 101.04 | 100.51 | 100.70 | 21770.00 |
Oct 16, 2024 | 98.27 | 100.48 | 98.27 | 100.20 | 20077.00 |
Oct 15, 2024 | 100.80 | 100.96 | 99.37 | 100.55 | 20749.00 |
Oct 14, 2024 | 100.92 | 101.03 | 100.65 | 100.67 | 22794.00 |
Oct 11, 2024 | 96.94 | 100.37 | 96.94 | 100.19 | 18473.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
73.10
Minimum
Oct 20 2023
117.74
Maximum
Nov 24 2020
99.20
Average
99.60
Median
Price Benchmarks
Alterity Therapeutics Ltd | 1.17 |
Kazia Therapeutics Ltd | 5.27 |
Immutep Ltd | 2.09 |
Opthea Ltd | 3.38 |
Mesoblast Ltd | 11.32 |
Price Related Metrics
PE Ratio | 33.66 |
PS Ratio | 6.053 |
PEG Ratio | 2.485 |
Price to Book Value | 5.115 |
Earnings Yield | 2.97% |
Market Cap | 88.81B |
PEGY Ratio | 2.246 |
Operating PE Ratio | 32.17 |
Normalized PE Ratio | 33.66 |